113 related articles for article (PubMed ID: 23237919)
1. Immunomodulators: particulate promotion of tolerance.
Tse MT
Nat Rev Drug Discov; 2013 Jan; 12(1):22-3. PubMed ID: 23237919
[No Abstract] [Full Text] [Related]
2. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.
Getts DR; Martin AJ; McCarthy DP; Terry RL; Hunter ZN; Yap WT; Getts MT; Pleiss M; Luo X; King NJ; Shea LD; Miller SD
Nat Biotechnol; 2012 Dec; 30(12):1217-24. PubMed ID: 23159881
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.
Gerdoni E; Gallo B; Casazza S; Musio S; Bonanni I; Pedemonte E; Mantegazza R; Frassoni F; Mancardi G; Pedotti R; Uccelli A
Ann Neurol; 2007 Mar; 61(3):219-27. PubMed ID: 17387730
[TBL] [Abstract][Full Text] [Related]
4. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
5. Immune tolerance mediated by recombinant proteolipid protein prevents experimental autoimmune encephalomyelitis.
Elliott EA; Cofiell R; Wilkins JA; Raine CS; Matis LA; Mueller JP
J Neuroimmunol; 1997 Oct; 79(1):1-11. PubMed ID: 9357441
[TBL] [Abstract][Full Text] [Related]
6. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation.
Ruiz PJ; Garren H; Ruiz IU; Hirschberg DL; Nguyen LV; Karpuj MV; Cooper MT; Mitchell DJ; Fathman CG; Steinman L
J Immunol; 1999 Mar; 162(6):3336-41. PubMed ID: 10092787
[TBL] [Abstract][Full Text] [Related]
7. Targeting DEC-205
Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
[TBL] [Abstract][Full Text] [Related]
8. Immune tolerance to myelin proteins.
Seamons A; Perchellet A; Goverman J
Immunol Res; 2003; 28(3):201-21. PubMed ID: 14713715
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 7 is a potent co-stimulator of myelin specific T cells that enhances the adoptive transfer of experimental autoimmune encephalomyelitis.
Bebo BF; Schuster JC; Adlard K; Vandenbark AA; Offner H
Cytokine; 2000 Apr; 12(4):324-31. PubMed ID: 10805212
[TBL] [Abstract][Full Text] [Related]
10. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells.
Hofstetter HH; Shive CL; Forsthuber TG
J Immunol; 2002 Jul; 169(1):117-25. PubMed ID: 12077236
[TBL] [Abstract][Full Text] [Related]
11. Differential control of neonatal tolerance by antigen dose versus extended exposure and adjuvant.
Min B; Legge KL; Caprio JC; Li L; Gregg R; Zaghouani H
Cell Immunol; 2000 Feb; 200(1):45-55. PubMed ID: 10716882
[TBL] [Abstract][Full Text] [Related]
12. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease.
Ichikawa HT; Williams LP; Segal BM
J Immunol; 2002 Sep; 169(5):2781-7. PubMed ID: 12193753
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived heat shock protein 70-peptide complexes induce NK cell-dependent tolerance to experimental autoimmune encephalomyelitis.
Galazka G; Stasiolek M; Walczak A; Jurewicz A; Zylicz A; Brosnan CF; Raine CS; Selmaj KW
J Immunol; 2006 Feb; 176(3):1588-99. PubMed ID: 16424188
[TBL] [Abstract][Full Text] [Related]
14. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis.
Nicholson LB; Greer JM; Sobel RA; Lees MB; Kuchroo VK
Immunity; 1995 Oct; 3(4):397-405. PubMed ID: 7584131
[TBL] [Abstract][Full Text] [Related]
15. Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis.
Luca ME; Kel JM; van Rijs W; Wouter Drijfhout J; Koning F; Nagelkerken L
J Neuroimmunol; 2005 Mar; 160(1-2):178-87. PubMed ID: 15710471
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis.
Zhang H; Podojil JR; Luo X; Miller SD
J Immunol; 2008 Oct; 181(7):4638-47. PubMed ID: 18802066
[TBL] [Abstract][Full Text] [Related]
17. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
[TBL] [Abstract][Full Text] [Related]
18. Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice.
Fritz RB; Zhao ML
J Neurosci Res; 1996 Aug; 45(4):471-4. PubMed ID: 8872908
[TBL] [Abstract][Full Text] [Related]
19. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
[TBL] [Abstract][Full Text] [Related]
20. Myelin protein expression in lymphoid tissues: implications for peripheral tolerance.
Voskuhl RR
Immunol Rev; 1998 Aug; 164():81-92. PubMed ID: 9795766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
